China Pharma has scalable GMP certified manufacturing facilities with eight different modern production lines. The Company has invested $6.25 million to expand and upgrade its facilities. It plans to invest another $3.0 million in 2007 to increase capacity and build a production line dedicated to antibiotics. China Pharma’s cutting edge production lines can manufacture products in the following forms of delivery: tablets; capsules; injectables; granules; oral fluids (suspension); and freeze dried (lyophilized injectables). Its production capacity fully satisfies the needs of the current portfolio.